INFY Stock Analysis: Infosys | NYSE
Information Technology Services | NYSE, USA | Market Cap: 43.541m USD | 12M Return: -32.4% | US4567881085 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 169M
EPS Trend: 88.4%
Qual. Beats: -1
Rev. Trend: 98.4%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Infosys Limited is a global provider of consulting, technology, outsourcing, and digital services, headquartered in Bengaluru, India. The company offers a broad portfolio spanning AI and generative AI services (including its Infosys Topaz suite), blockchain, IoT, cybersecurity, cloud and enterprise modernization, digital marketing, and industry-specific platforms such as Finacle (banking) and Cobalt (cloud). It serves virtually every major industry vertical, from financial services and healthcare to manufacturing, energy, and the public sector.
As one of Indias flagship IT services exporters, Infosys operates within a labor-arbitrage business model that monetizes a large, India-based talent pool delivering work for clients in North America, Europe, and other markets. The IT consulting and services sector is highly competitive, with pricing tied largely to billable hours and offshore-onsite mix, making workforce utilization and digital capabilities like AI key levers for margin expansion. The company was incorporated in 1981 and listed on the NYSE in 1999.
- Infosys Topaz AI deal pipeline accelerates with enterprise clients
- US visa policy tightening pressures Indian IT margins and onsite costs
- Financial services vertical spending rebounds boosting BFSI segment revenue
- Large deal TCV growth signals strong demand visibility
- Currency headwinds from rupee volatility impact reported revenue
- Generative AI pricing pressures compress traditional outsourcing billing rates
| Net Income: 3.32b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.23 > 0.02 and ΔFCF/TA 0.76 > 1.0 |
| NWC/Revenue: 23.73% < 20% (prev 31.23%; Δ -7.50% < -1%) |
| CFO/TA 0.25 > 3% & CFO 4.11b > Net Income 3.32b |
| Net Debt (-1.64b) to EBITDA (5.13b): -0.32 < 3 |
| Current Ratio: 1.86 > 1.5 & < 3 |
| Outstanding Shares: last quarter (4.09b) vs 12m ago -1.34% < -2% |
| Gross Margin: 30.32% > 18% (prev 30.46%; Δ -0.14% > 0.5%) |
| Asset Turnover: 120.1% > 50% (prev 111.8%; Δ 8.32% > 0%) |
| Interest Coverage Ratio: 95.82 > 6 (EBIT TTM 4.58b / Interest Expense TTM 47.8m) |
| A: 0.29 (Total Current Assets 10.4b - Total Current Liabilities 5.59b) / Total Assets 16.4b |
| B: 0.50 (Retained Earnings 8.18b / Total Assets 16.4b) |
| C: 0.27 (EBIT TTM 4.58b / Avg Total Assets 16.9b) |
| D: 1.44 (Book Value of Equity 9.62b / Total Liabilities 6.68b) |
| Altman-Z'' = 6.89 = AAA |
| DSRI: 0.95 (Receivables 5.33b/5.37b, Revenue 20.3b/19.5b) |
| GMI: 1.00 (GM 30.46% / 30.32%) |
| AQI: 1.04 (AQ_t 0.24 / AQ_t-1 0.23) |
| SGI: 1.04 (Revenue 20.3b / 19.5b) |
| TATA: -0.05 (NI 3.32b - CFO 4.11b) / TA 16.4b) |
| Beneish M = -3.01 (Cap -4..+1) = AA |
As of September 30, 2026, the stock is trading at USD 10.64 with a total of 13,183,978 shares traded. Over the past week, the price has changed by -1.12%, over one month by -11.77%, over three months by -0.56% and over the past year by -32.39%.
Current recommended Stop Loss: 10.20 (which is 4.1% or 1.4 ATR below the current price).
Infosys has received a consensus analysts rating of 3.71. Therefore, it is recommended to hold INFY.
- StrongBuy: 4
- Buy: 2
- Hold: 8
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 11.9 | 11.4% |
P/E Trailing = 13.2716
P/E Forward = 13.2979
P/S = 2.145
P/B = 4.5308
P/EG = 1.821
Revenue TTM = 20.3b USD
EBIT TTM = 4.58b USD
EBITDA TTM = 5.13b USD
Long Term Debt = 563.0m USD (estimated: total debt 923.0m - short term 360.0m)
Short Term Debt = 360.0m USD (from shortTermDebt, last quarter)
Debt = 1.49b USD (from shortLongTermDebtTotal, last quarter) + Leases 563.0m
Net Debt = -1.64b USD (calculated: Debt 1.49b - CCE 3.12b)
Enterprise Value = 41.9b USD (43.5b + Debt 1.49b - CCE 3.12b)
Interest Coverage Ratio = 95.82 (Ebit TTM 4.58b / Interest Expense TTM 47.8m)
EV/FCF = 10.97x (Enterprise Value 41.9b / FCF TTM 3.82b)
FCF Yield = 9.11% (FCF TTM 3.82b / Enterprise Value 41.9b)
FCF Margin = 18.82% (FCF TTM 3.82b / Revenue TTM 20.3b)
Net Margin = 16.38% (Net Income TTM 3.32b / Revenue TTM 20.3b)
Gross Margin = 30.32% ((Revenue TTM 20.3b - Cost of Revenue TTM 14.1b) / Revenue TTM)
Gross Margin QoQ = 31.48% (prev 30.85%)
Tobins Q-Ratio = 2.56 (Enterprise Value 41.9b / Total Assets 16.4b)
Interest Expense / Debt = 3.22% (Interest Expense 47.8m / Debt 1.49b)
Taxrate = 26.57% (1.20b / 4.53b)
NOPAT = 3.36b (EBIT 4.58b * (1 - 26.57%))
Current Ratio = 1.86 (Total Current Assets 10.4b / Total Current Liabilities 5.59b)
Debt / Equity = 0.15 (Debt 1.49b / totalStockholderEquity, last quarter 9.62b)
Debt / EBITDA = -0.32 (Net Debt -1.64b / EBITDA 5.13b)
Debt / FCF = -0.43 (Net Debt -1.64b / FCF TTM 3.82b)
Total Stockholder Equity = 10.1b (last 4 quarters mean from totalStockholderEquity)
RoA = 19.66% (Net Income 3.32b / Total Assets 16.4b)
RoE = 33.01% (Net Income TTM 3.32b / Total Stockholder Equity 10.1b)
RoCE = 43.07% (EBIT 4.58b / Capital Employed (Equity 10.1b + L.T.Debt 563.0m))
RoIC = 33.24% (NOPAT 3.36b / Invested Capital 10.1b)
WACC = 7.92% (E(43.5b)/V(45.0b) * Re(8.11%) + D(1.49b)/V(45.0b) * Rd(3.22%) * (1-Tc(0.27)))
Discount Rate = 8.11% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -31.99 | Cagr: -0.54%
[DCF] Terminal Value 75.01% ; FCFF base≈3.87b ; Y1≈3.78b ; Y5≈3.80b
[DCF] Fair Price = 15.09 (EV 59.5b - Net Debt -1.64b = Equity 61.1b / Shares 4.05b; r=8.35% [WACC [floored]]; 5y FCF grow -3.09% → 2.50% )
EPS Correlation: 88.40 | EPS CAGR: 4.94% | SUE: -1.32 | # QB: -1
Revenue Correlation: 98.35 | Revenue CAGR: 3.67% | SUE: -0.70 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.21 | Chg30d=-0.72% | Revisions=-29% | Analysts=7
EPS next Quarter (2026-12-31): EPS=0.20 | Chg30d=+0.00% | Revisions=-29% | Analysts=7
EPS current Year (2027-03-31): EPS=0.81 | Chg30d=+0.00% | Revisions=-50% | GrowthEPS=-3.0% | GrowthRev=+9.1%
EPS next Year (2028-03-31): EPS=0.85 | Chg30d=-0.36% | Revisions=-50% | GrowthEPS=+5.5% | GrowthRev=+3.8%
[Analyst] Revisions Ratio: -56% (up=4, down=18)